4SC AG / Key word(s): Corporate Action/Miscellaneous 04.03.2014 16:15 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Publication of an ad hoc release pursuant to Section 15 of the German Securities Trading Act (Wertpapierhandelsgesetz, WpHG) 4SC AG issues first tranche of convertible notes with a nominal amount of EUR 500,000 to Yorkville Planegg-Martinsried, 4 March 2014 - 4SC AG (Frankfurt, Prime Standard: VSC) today announced that it successfully completed the issuance of convertible notes with a nominal amount of EUR 500,000.00. These convertible notes constitute the first tranche of a total issuance of up to EUR 15 million guaranteed by an agreement between YA Global Master SPV Ltd. ("Yorkville") and the Company. Following the successful conversion of previously issued tranches, the Company's Management will decide independently on a case-by-case basis whether additional tranches will be issued. Excluding the pre-emptive rights of existing shareholders, the notes will be issued exclusively to Yorkville at a subscription price corresponding to 95% of the nominal amount. The notes carry no interest, have a term of nine month and may be converted into shares of 4SC by the holder of the notes at any time. The conversion price equals the volume weighted average trading price of 4SC shares during a five-day period prior to the time of conversion, less a 5% discount, but it cannot be lower than EUR 1.13. Further details regarding the terms and conditions in connection with the issuance of convertible notes according to the agreement with Yorkville were announced in the ad hoc release dated 12 February 2014. Ad hoc ends --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: About 4SC The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops targeted, small-molecule drugs for treating diseases with high unmet medical needs in various cancer and autoimmune indications. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious than existing therapies, and provide a better quality of life. The Company's pipeline comprises promising products that are in various stages of clinical development. 4SC's aim is to generate future growth and enhance its enterprise value by entering into partnerships with leading pharmaceutical and biotech companies. Founded in 1997, 4SC had a headcount of 78 employees (57 FTEs) at 30 September 2013. 4SC AG has been listed on the Prime Standard of the Frankfurt Stock Exchange since December 2005. Cautionary statement regarding forward-looking statements This press release contains certain forward-looking statements. Any forward-looking statement applies only on the date of this press release. By their nature, forward-looking statements are subject to a number of known and unknown risks and uncertainties that may or may not occur in the future and as a result of which the actual results and performance may differ substantially from the expected future results or performance expressed or implied in the forward looking statements. No warranties or representations are made as to the accuracy, achievement or reasonableness of such statements, estimates or projections, and 4SC AG has no obligation to update any such information or to correct any inaccuracies herein or omission herefrom which may become apparent. For more information please visit www.4sc.com or contact: 4SC AG Jochen Orlowski, Corporate Communications & Investor Relations jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-6366 MC Services Raimund Gabriel raimund.gabriel(at)mc-services.eu , Tel.: +49-89-2102-2830 The Trout Group Chad Rubin crubin(at)troutgroup.com, Tel.: +1-646-378-2947 04.03.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: 4SC AG Am Klopferspitz 19a 82152 Martinsried Germany Phone: +49 (0)89 7007 63-0 Fax: +49 (0)89 7007 63-29 E-mail: public@4sc.com Internet: www.4sc.de ISIN: DE0005753818 WKN: 575381 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: 4SC AG issues first tranche of convertible notes with a nominal amount of EUR 500,000 to Yorkville
| Source: EQS Group AG